[Preliminary evaluation of the commercial kit Chagas ( Trypanosoma cruzi ) IgG-ELISA ® in Colombian individuals].

Simple item page
dc.contributor.authorMónica Llano
dc.contributor.authorPaula Pavía
dc.contributor.authorAstrid Carolina Flórez
dc.contributor.authorAdriana Cuéllar
dc.contributor.authorJohn Mario González
dc.contributor.authorConcepción J. Puerta
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T15:06:33Z
dc.date.available2026-03-22T15:06:33Z
dc.date.issued2015
dc.descriptionCitaciones: 7
dc.description.abstractThe commercial ELISA test allowed us to discriminate the chagasic patients from the controls. A phase II study of diagnostic tests for determining field reliability of this test is required.
dc.identifier.doi10.1590/s0120-41572014000200009
dc.identifier.urihttps://doi.org/10.1590/s0120-41572014000200009
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/50431
dc.language.isoen
dc.publisherNational Institutes of Health
dc.relation.ispartofPubMed
dc.sourceInstituto Nacional de Salud
dc.subjectChagas disease
dc.subjectAsymptomatic
dc.subjectMedicine
dc.subjectTrypanosoma cruzi
dc.subjectVisceral leishmaniasis
dc.subjectSerology
dc.subjectInternal medicine
dc.subjectAsymptomatic carrier
dc.subjectEpidemiology
dc.subjectLeishmaniasis
dc.title[Preliminary evaluation of the commercial kit Chagas ( Trypanosoma cruzi ) IgG-ELISA ® in Colombian individuals].
dc.typearticle

Files

Collections

Artículo Científico Publicado